The hydrogel market is projected to reach USD 15.33 Billion by 2022, at a CAGR of 6.04%. The growth of the hydrogel market can be attributed to an increase in consumption of personal care & hygiene products in emerging economies and rise in the production facilities of hydrogels.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=181614457
Based on application, the agriculture segment is anticipated to grow at the highest CAGR during the forecast period. This growth can be attributed to the increasing agricultural activities in various regions, such as Asia Pacific, North America, Europe, and the Middle East & Africa. Moreover, the growing usage of hydrogels as a key material for farming, owing to its characteristics such as water holding ability, has contributed to the growth of the hydrogel market in agriculture.
The polyacrylate segment of the hydrogel market is anticipated to grow at the highest CAGR. This growth can be attributed to the water retention ability of polyacrylate hydrogels that increase their applicability in the personal care & hygiene application. Moreover, superior properties of hydrogels, such as transparency and elasticity, have further led to the growth of the polyacrylate segment.
Target Audience:
Raw Material Suppliers
Logistics Partners
Machinery Suppliers
Regulatory Bodies
Market Research and Consulting Firms
Asia Pacific accounted for the largest share of the hydrogel market. Among all countries in the Asia Pacific region, the hydrogel market in India is projected to grow at the highest CAGR. This market in North America is projected to grow at the second-highest CAGR between 2017 and 2022, with the US registering the highest growth rate in this region.
Key players operating in the hydrogel market include Johnson & Johnson (US), Cardinal Health (US), the 3M Company (US), Coloplast (Denmark), B. Braun Melsungen (Germany), Smith & Nephew (UK), Derma Sciences (US), Royal DSM (Netherlands), Dow Corning Corporation (US), Paul Hartmann (Germany), Momentive Performance Materials (US), Ocular Therapeutix (US), ConvaTec (UK), Ashland (US), Evonik Industries (Germany), Cosmo Bio USA (US), MPM Medical (US), Molnlycke Health Care (Sweden), Hollister (US), Medline Industries (US), Gentell (US), and Alliqua BioMedical (US). These players have adopted various growth strategies to expand their global presence and increase their market share. Mergers & acquisitions, expansions, and new product launches are some of the major strategies adopted by key players operating in the hydrogel market.
Get in-depth analysis of the COVID-19 impact on the Hydrogel Market
Bench marking the rapid strategy shifts of the Top 100 companies in the Hydrogel Market: https://www.marketsandmarkets.com/RequestCOVID19.asp?id=181614457
Comments